Literature DB >> 22588341

Vasospasm after spontaneous angiographically negative subarachnoid hemorrhage.

Bradley A Gross1, Ning Lin, Kai U Frerichs, Rose Du.   

Abstract

BACKGROUND: Vasospasm, delayed infarcts and clinical deterioration due to delayed cerebral ischemia (CD-DCI) following digital subtraction angiography (DSA)-negative, spontaneous subarachnoid hemorrhage (SAH) are infrequently and inconsistently described in the literature.
METHODS: To quantify and characterize rates of each, we reviewed our own series of 77 patients with DSA-negative, spontaneous SAH. Employing a PubMed search, we reviewed the literature and calculated directly adjusted overall rates of vasospasm, delayed infarcts and CD-DCI.
RESULTS: In our own patient cohort, 26 % of patients suffered vasospasm, 4 % delayed infarcts and 4 % CD-DCI. Higher Hunt-Hess grade and diffuse SAH pattern were associated with higher rates of each. Incorporating results from 18 studies in the literature, the directly adjusted overall rate of vasospasm following DSA-negative SAH was 16.3 % (95 % CI 12.3-21.1). Adjusted overall rates of delayed infarcts and CD-DCI were 3.4 % (95 % CI 1.9-5.5) and 6.8 % (95 % CI 5.0-9.1), respectively. For the subgroup of patients with diffuse SAH, the rates of vasospasm and CD-DCI were 31.3 % (95 % CI 21.6-43.9) and 9.7 % (95 % CI 7.0-13.0), respectively, while in patients with perimesencephalic SAH, respective rates were 13.1 % (95 % CI 7.7-20.7) and 2.4 % (95 % CI 1.0-4.8). A mixed-effects meta-analysis revealed an odds ratio for CD-DCI in diffuse SAH compared to perimesencephalic SAH of 3.79 (p = 0.009).
CONCLUSION: Although they are seen less frequently in patients with DSA-negative spontaneous SAH, vasospasm, delayed infarcts and CD-DCI do occur and may require endovascular therapy. Risk factors include a diffuse hemorrhage pattern and higher Hunt-Hess grade.

Entities:  

Mesh:

Year:  2012        PMID: 22588341     DOI: 10.1007/s00701-012-1383-4

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  7 in total

1.  A population-based study of the incidence and case fatality of non-aneurysmal subarachnoid hemorrhage.

Authors:  Adnan I Qureshi; Nauman Jahangir; Mushtaq H Qureshi; Archie Defillo; Ahmed A Malik; Gregory T Sherr; M Fareed K Suri
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

2.  MRI Detection of Cerebral Infarction in Subarachnoid Hemorrhage.

Authors:  Georgia Korbakis; Shyam Prabhakaran; Sayona John; Rajeev Garg; James J Conners; Thomas P Bleck; Vivien H Lee
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

3.  Description of the vasospasm phenomena following perimesencephalic nonaneurysmal subarachnoid hemorrhage.

Authors:  Daphna Prat; Oded Goren; Bela Bruk; Mati Bakon; Moshe Hadani; Sagi Harnof
Journal:  Biomed Res Int       Date:  2013-12-28       Impact factor: 3.411

4.  Ultrasound guided double injection of blood into cisterna magna: a rabbit model for treatment of cerebral vasospasm.

Authors:  Yongchao Chen; Youzhi Zhu; Yu Zhang; Zixuan Zhang; Juan Lian; Fucheng Luo; Xuefei Deng; Kelvin K L Wong
Journal:  Biomed Eng Online       Date:  2016-02-06       Impact factor: 2.819

5.  Subarachnoid haemorrhage with negative initial neurovascular imaging: a systematic review and meta-analysis.

Authors:  Midhun Mohan; Abdurrahman I Islim; Fahid T Rasul; Ola Rominiyi; Ruth-Mary deSouza; Michael T C Poon; Aimun A B Jamjoom; Angelos G Kolias; Julie Woodfield; Krunal Patel; Aswin Chari; Ramez Kirollos
Journal:  Acta Neurochir (Wien)       Date:  2019-08-13       Impact factor: 2.216

6.  Novel Subgroups in Subarachnoid Hemorrhage and Their Association With Outcomes-A Systematic Review and Meta-Regression.

Authors:  Ming-Dong Wang; Qian-Hui Fu; Ming-Jing Song; Wen-Bin Ma; John-H Zhang; Zhan-Xiang Wang
Journal:  Front Aging Neurosci       Date:  2021-01-11       Impact factor: 5.750

7.  Development of a nomogram for predicting clinical outcome in patients with angiogram-negative subarachnoid hemorrhage.

Authors:  Anke Zhang; Zeyu Zhang; Wen-Bo Zhang; Xiaoyu Wang; Cameron Lenahan; Yuanjian Fang; Yujie Luo; Yibo Liu; Shuhao Mei; Sheng Chen; Jianmin Zhang
Journal:  CNS Neurosci Ther       Date:  2021-07-28       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.